Dominic RPh - MannKind Corp President Unit
| MNKD Stock | USD 5.78 0.43 6.92% |
President
Dominic RPh is President Unit of MannKind Corp
| Age | 54 |
| Address | 1 Casper Street, Danbury, CT, United States, 06810 |
| Phone | 818 661 5000 |
| Web | https://www.mannkindcorp.com |
MannKind Corp Management Efficiency
The company has return on total asset (ROA) of 0.0995 % which means that it generated a profit of $0.0995 on every $100 spent on assets. This is way below average. MannKind Corp's management efficiency ratios could be used to measure how well MannKind Corp manages its routine affairs as well as how well it operates its assets and liabilities. At present, MannKind Corp's Return On Assets are projected to increase slightly based on the last few years of reporting. At present, MannKind Corp's Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 37.9 M, whereas Non Current Assets Total are forecasted to decline to about 87.7 M.Similar Executives
| Found 4 records | PRESIDENT Age | ||
| Sarah Cavanaugh | Celldex Therapeutics | 51 | |
| Sam Martin | Celldex Therapeutics | 53 | |
| Kimberly Gentile | Biohaven Pharmaceutical Holding | 60 | |
| Elizabeth Crowley | Celldex Therapeutics | 54 | |
Management Performance
| Return On Asset | 0.0995 |
MannKind Corp Leadership Team
Elected by the shareholders, the MannKind Corp's board of directors comprises two types of representatives: MannKind Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of MannKind. The board's role is to monitor MannKind Corp's management team and ensure that shareholders' interests are well served. MannKind Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, MannKind Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| John Bedard, Senior Affairs | ||
| Burkhard MD, Executive Officer | ||
| Stuart Tross, Chief People Officer | ||
| Christopher MBA, Chief Officer | ||
| Lauren Sabella, Executive Operations | ||
| Michael PharmD, CEO Director | ||
| McCauley JD, Chief Officer | ||
| David Thomson, Corporate Vice President General Counsel, Corporate Secretary | ||
| MD MBA, Chief Officer | ||
| Rosabel Alinaya, Acting CFO, Senior Vice President Chief Accounting Officer | ||
| MS MBA, Chief Officer | ||
| Rosabel CPA, VP Treasury | ||
| Matthew PharmD, Senior Unit | ||
| Kevin MD, Senior Diseases | ||
| Dominic RPh, President Unit | ||
| Sanjay MBA, Executive Operations | ||
| Steven Binder, CFO, Principal Accounting Officer | ||
| Thomas MD, Chief Officer | ||
| Dr JD, General VP |
MannKind Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is MannKind Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | 0.0995 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.23 % | ||||
| Current Valuation | 1.64 B | ||||
| Shares Outstanding | 307.07 M | ||||
| Shares Owned By Insiders | 1.64 % | ||||
| Shares Owned By Institutions | 55.15 % | ||||
| Number Of Shares Shorted | 27.3 M | ||||
| Price To Earning | 2.27 X | ||||
| Price To Sales | 5.39 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether MannKind Corp is a strong investment it is important to analyze MannKind Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact MannKind Corp's future performance. For an informed investment choice regarding MannKind Stock, refer to the following important reports:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MannKind Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. For information on how to trade MannKind Stock refer to our How to Trade MannKind Stock guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Will Biotechnology sector continue expanding? Could MannKind diversify its offerings? Factors like these will boost the valuation of MannKind Corp. Expected growth trajectory for MannKind significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every MannKind Corp data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.35) | Earnings Share 0.1 | Revenue Per Share | Quarterly Revenue Growth 0.172 | Return On Assets |
Investors evaluate MannKind Corp using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating MannKind Corp's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause MannKind Corp's market price to deviate significantly from intrinsic value.
Understanding that MannKind Corp's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether MannKind Corp represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, MannKind Corp's market price signifies the transaction level at which participants voluntarily complete trades.